FABP4 and cancer: In fact, real-time cellular metabolic analysis using a Seahorse bioanalyzer showed that pharmacological inhibition of FABP4 in HOCF by BMS309403 led to pseudohypoxic changes that may be a critical cause of neovascularization in AMD [24] and malignant tumors [25,26].